Market requirements · ES
Spain
AEMPS has issued a formal notice on illegal GLP-1 supply and directs buyers to verify pharmacies through the Distafarma registry and the EU common logo.
Buyers in this market search for: peptidos al por mayor, proveedor de peptidos, marca blanca.
| Tell us the compounds you need for Spain. | Ask about Spain |
The regime
How compounds are classified in Spain
| Governing law | Spanish medicines law, administered by AEMPS. Advertising is governed by Ley 29/2006 and Real Decreto 1416/1994. |
|---|---|
| The regulator's stated position | AEMPS issued a formal notice, Nota Informativa 26/2025 of 3 September 2025, jointly with EMA and HMA, on the sharp rise in illegal medicines sold as GLP-1 analogues, naming semaglutide, liraglutide and tirzepatide. The notice states that prescription medicines cannot be legally sold online in Spain under any circumstance. |
| A verification mechanism worth knowing | AEMPS directs buyers to verify legal online pharmacies through the Distafarma registry and the EU common logo, and describes any site lacking it as operating illegally. That is a public checking tool, which means your downstream customers are checkable by anyone, including a regulator. |
| Advertising | Public advertising of prescription medicines is prohibited outright. Promotion to healthcare professionals is permitted only under restricted conditions. Consumer-facing promotion of these compounds sits outside the lawful advertising channel. |
| Enforcement posture | AEMPS describes large-scale fraudulent online listings, many hosted outside the EU, some misusing official EMA and AEMPS logos. |
| Already supplying Spain? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Spain needs settled
- Hold the Spanish authorisation your intended activity requires before importing.
- Check that your own downstream customers can withstand a Distafarma check, because a regulator can run it as easily as you can.
- Keep all Spanish-facing material out of consumer-facing promotion entirely.
- Take Spanish counsel before supplying into the market.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| AEMPS Nota Informativa 26/2025, issued with EMA and HMA, on illegal medicines sold as GLP-1 analogues | 3 September 2025 | www.aemps.gob.es/informa/la-ema-y-hma-advierten-del-aument... |
| BOE Real Decreto 1416/1994 on medicines advertising | 1994 | www.boe.es/buscar/act.php?id=BOE-A-1994-17681 |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Spain brief as a PDF
The regime, the buyer obligations and all 2 sources, dated and linked, in one document you can forward.
Nearby
Southern Europe and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| FR | France | 3 sources | ANSM names compounds individually in its public alerts and has issued sanitary... |
| IT | Italy | 1 sources | AIFA regulates under the Codice del farmaco and has warned on illegal GLP-1 su... |
| PT | Portugal | 5 sources | INFARMED governs medicines under the Estatuto do Medicamento and has flagged a... |
| GR | Greece | 4 sources | EOF issued a public warning in July 2026, and related reporting names specific... |
| AT | Austria | 3 sources | BASG has published a dedicated position holding that a research-use label does... |
| CH | Switzerland | 5 sources | Swissmedic regulates therapeutic products under the Heilmittelgesetz and runs ... |
Scope
How to use this page
A summary of the published regulatory position in Spain as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Spain
Do you supply into Spain?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Spain depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Spain. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Spain
Tell us the compounds and your authorisations. We confirm per compound before anything ships.